Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory ITP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07574073
What this trial is testing

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Who this might be right for
Anti-CD20 Monoclonal AntibodyBTK InhibitorsImmune Thrombocytopenia (ITP)+1 more
Qi deng 30
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00102739
What this trial is testing

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 99
Testing effectiveness (Phase 2)UnknownNCT05315778
What this trial is testing

Anti-BCMA CAR T-Cell Therapy for R/R ITP

Who this might be right for
ITP
The First Affiliated Hospital of Soochow University 5
Early research (Phase 1)Looking for participantsNCT07315087
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Large-scale testing (Phase 3)Study completedNCT00102323
What this trial is testing

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 63
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Very early researchNot Yet RecruitingNCT07416032
What this trial is testing

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Very early researchLooking for participantsNCT06519565
What this trial is testing

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Very early researchUnknownNCT05930314
What this trial is testing

CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus ErythematosusLupus NephritisImmune Thrombocytopenia
Peking Union Medical College Hospital 12
Early research (Phase 1)Looking for participantsNCT06941129
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myopathy+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Very early researchLooking for participantsNCT06337474
What this trial is testing

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia Alloimmune
Changzhou No.2 People's Hospital 9
Testing effectiveness (Phase 2)UnknownNCT03460808
What this trial is testing

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 200